We are live on ! Find out more
PIP

Permian Investment Partners Portfolio holdings

AUM $911M
1-Year Est. Return 0.66%
This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+0.66%
3 Year Est. Return
+78.59%
5 Year Est. Return
+147.03%
10 Year Est. Return
+743.92%
AUM
$153M
AUM Growth
+$6.67M
Cap. Flow
-$809K
Cap. Flow %
-0.53%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
5
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
AMRI
Albany Molecular Research Inc
AMRI
+$11.4M
2
ENDP
Endo International plc
ENDP
+$4.75M
3
BLKB icon
Blackbaud
BLKB
+$3.4M
4
SEE
Sealed Air
SEE
+$3.31M
5
ESL
Esterline Technologies
ESL
+$2.21M

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$19.5M
2
FRX
FOREST LABORATORIES INC
FRX
+$5.44M
3
LVLT
Level 3 Communications Inc
LVLT
+$839K

Sector Composition

Rank Sector Weight
1 Healthcare 44.46%
2 Consumer Discretionary 24.15%
3 Technology 19.78%
4 Industrials 10.51%
5 Miscellaneous 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
1
DELISTED
Endo International plc
ENDP
$49.8M 32.57%
711,015
+71,000
+11% +$4.75M
SEE
2
DELISTED
Sealed Air
SEE
$36.9M 24.15%
1,080,332
+100,000
+10% +$3.31M
ESL
3
DELISTED
Esterline Technologies
ESL
$22.4M 14.69%
195,000
+20,000
+11% +$2.21M
AMRI
4
DELISTED
Albany Molecular Research Inc
AMRI
$13.5M 8.82%
+670,190
New +$11.4M
TDG icon
5
TransDigm Group
TDG
$64B
$12.5M 8.21%
75,000
-108,400
-59% -$19.5M
BLKB icon
6
Blackbaud
BLKB
$2.2B
$7.78M 5.09%
217,766
+102,045
+88% +$3.4M
AGN
7
DELISTED
Allergan plc
AGN
$4.68M 3.06%
21,000
– –
LVLT
8
DELISTED
Level 3 Communications Inc
LVLT
$3.51M 2.3%
80,000
-20,000
-20% -$839K
ENDP
9
CALL
DELISTED
Endo International plc
ENDP
$1.69M 1.11%
230,000
+220,000
+2,200% +$14.7M
FRX
10
DELISTED
FOREST LABORATORIES INC
FRX
– –
-59,000
Closed -$5.44M

Similar funds

NCM
Nelson Capital Management Menlo Park, California $912M AUM 24.01% 1-Year Est. Return
JSL
JT Stratford LLC Gainesville, Georgia $912M AUM 34.38% 1-Year Est. Return
CG
Castellan Group Louisville, Kentucky $912M AUM 55.71% 1-Year Est. Return
WCM
Wallace Capital Management Dallas, Texas $912M AUM 21.45% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $913M AUM
IPAM
ICICI Prudential Asset Management Mumbai, India $913M AUM 30.42% 1-Year Est. Return
PLFA
Pacific Life Fund Advisors Newport Beach, California $910M AUM 20.54% 1-Year Est. Return
FWA
FORM Wealth Advisors Lake Geneva, Wisconsin $909M AUM

Permian Investment Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Permian Investment Partners held 10 positions worth $153M, up 4.6% from $146M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Permian Investment Partners's Q2 2014 filing shows 1 new, 5 increased, 2 reduced and 1 closed positions. Its largest new stake was Albany Molecular Research Inc: 670,190 shares worth $13.5M. The largest sale was TransDigm Group, an estimated $19.5M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Permian Investment Partners's largest Q2 2014 buy was Albany Molecular Research Inc: 670,190 shares worth $13.5M.
  • Permian Investment Partners added most to Endo International plc in Q2 2014, an estimated $4.75M increase.
  • Permian Investment Partners's biggest Q2 2014 reduction was TransDigm Group, cutting an estimated $19.5M.
  • Permian Investment Partners fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $5.44M.
  • Permian Investment Partners's ten largest holdings make up 100% of its $153M portfolio in Q2 2014.
  • Permian Investment Partners opened 1 new position and closed 1 in Q2 2014.
  • Permian Investment Partners's portfolio value rose 4.6% quarter-over-quarter to $153M.

Based on Permian Investment Partners's 13F filing for Q2 2014, filed 14 Aug 2014.